Mar Llamas-Velasco Selected Research

Hidradenitis Suppurativa

1/2023

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mar Llamas-Velasco Research Topics

Disease

40	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 12/2013
11	Neoplasms (Cancer) 01/2024 - 04/2015
5	Psoriatic Arthritis 12/2023 - 09/2018
4	Necrosis 10/2023 - 06/2015
2	Inflammation (Inflammations) 03/2024 - 01/2023
2	Atherosclerosis 03/2024 - 11/2023
2	Infections 01/2024 - 10/2023
2	Mycoses (Diseases, Fungus) 01/2023 - 06/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2020 - 05/2014
2	Cysts 01/2019 - 04/2018
2	Erythema 03/2018 - 03/2013
2	Histiocytosis 09/2017 - 06/2015
2	Panniculitis 06/2015 - 01/2013
2	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 05/2015 - 01/2013
1	Insulin Resistance 03/2024
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 02/2024
1	Tuberculosis (Tuberculoses) 01/2024
1	Latent Tuberculosis 01/2024
1	Atherosclerotic Plaque (Atheroma) 11/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Hidradenitis Suppurativa 01/2023
1	Multiple Sclerosis 01/2023
1	Spondylarthritis (Spinal Arthritis) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Axial Spondyloarthritis 01/2023
1	Skin Manifestations 11/2022
1	Rheumatoid Arthritis 08/2022
1	Non-alcoholic Fatty Liver Disease 06/2022
1	Liver Diseases (Liver Disease) 06/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Obesity 12/2021
1	Skin Neoplasms (Skin Cancer) 10/2021
1	Melanoma (Melanoma, Malignant) 10/2021
1	COVID-19 02/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021
1	Hypopigmentation (Hypomelanosis) 11/2020
1	Lymphopenia (Lymphocytopenia) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020

Drug/Important Bio-Agent (IBA)

8	secukinumabIBA 01/2024 - 09/2018
5	Interleukin-23 (Interleukin 23)IBA 01/2024 - 11/2022
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2016
4	Adalimumab (Humira)FDA Link 11/2022 - 12/2013
3	InterleukinsIBA 02/2024 - 11/2022
3	Interleukin-17 (Interleukin 17)IBA 01/2024 - 01/2023
3	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 07/2020
3	guselkumabIBA 11/2022 - 01/2022
3	Ustekinumab (CNTO 1275)FDA Link 10/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2020
3	Etanercept (Enbrel)FDA Link 07/2020 - 06/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2024 - 02/2022
2	C-Reactive ProteinIBA 03/2024 - 11/2020
2	MucinsIBA 01/2024 - 01/2021
2	tildrakizumabIBA 12/2023 - 10/2023
2	Dimethyl FumarateIBA 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 08/2022 - 01/2019
2	AntibodiesIBA 06/2022 - 01/2019
2	InterferonsIBA 11/2020 - 01/2016
2	Infliximab (Remicade)FDA Link 07/2020 - 01/2018
2	Acitretin FDA Link 07/2020 - 12/2013
2	CollagenIBA 03/2019 - 01/2019
2	Keratins (Keratin)IBA 06/2018 - 04/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2018 - 01/2013
1	Certolizumab Pegol FDA Link 05/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024
1	HDL LipoproteinsIBA 03/2024
1	CCR4 ReceptorsIBA 02/2024
1	mogamulizumabIBA 02/2024
1	Tumor Necrosis Factor InhibitorsIBA 01/2024
1	ixekizumabIBA 01/2024
1	Oxygen (Dioxygen)IBA 11/2023
1	Complement System Proteins (Complement)IBA 11/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Monoclonal AntibodiesIBA 11/2022
1	Biosimilar PharmaceuticalsIBA 11/2022
1	DesminIBA 06/2022
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 02/2022
1	CytokinesIBA 02/2022
1	EnzymesIBA 02/2022
1	Tissue Inhibitor of Metalloproteinase-3IBA 02/2022
1	RivaroxabanIBA 01/2022
1	FibrinIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	calcipotriene (calcipotriol)FDA LinkGeneric 10/2021
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 10/2021
1	Ferritins (Ferritin)IBA 11/2020
1	Tyrosine Kinase InhibitorsIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	fibrin fragment D (D-dimer)IBA 11/2020
1	apremilastIBA 07/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2020

Therapy/Procedure

10	Therapeutics 10/2023 - 01/2018
8	Biological Therapy 01/2024 - 12/2018
3	Drug Therapy (Chemotherapy) 02/2015 - 01/2013
2	Aftercare (After-Treatment) 10/2022 - 01/2020
1	Chemoprevention 01/2024
1	Drug Tapering 01/2024
1	Pain Management 01/2022